FDA approves IG Subcutaneous

January 10, 2006 8:37 PM | | Comments (0)

FDA today announced the approval of immune globulin for subcutaneous injection use for the prevention of serious infections in patients with Primary Immune Deficiency. The manufacturer is ZLB Behring.

Read news via FDA here.

Read the product page via ZLB Behring here.
vivaglobulin.gif

Categories

News & Blogs , Primary Immunodeficiency

Leave a comment

About this Entry

This page contains a single entry by published on January 10, 2006 8:37 PM.

Banco de células madre de cordón umbilical en México was the previous entry in this blog.

More about the Cord Blood Stem Cell act of 2005 is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Subscribe to feed Subscribe to this blog's feed
Powered by Movable Type 4.0

Search